and adverse drug events (ADEs) are both common and under-reported in the intensive care setting. The definitions of these terms vary substantially in the literature. Many methods have been used to ...

We investigated the top drugs associated with HF and acute HF (AHF) reported in the FDA Adverse Event Reporting System (FAERS). Methods: We reviewed publicly available FAERS databases from 2004 to ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

It was approved by the FDA in 2020 for the treatment of relapsing multiple sclerosis (RMS ... We applied four distinct methodologies, including ROR, PRR, MGPS, and BCPNN, to perform a ...

Objective To determine how often serious or life-threatening medication administration errors with the potential to cause harm (potential adverse drug events) result in actual harm (adverse drug ...

database to identify common and repeated patterns of preventable adverse drug events (ADEs) was analyzed. ADR reports collected from 1994 through 2000 were extracted from a teaching hospital's ADR ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from ... very good or excellent at ...

Panelists discuss common adverse events associated with subcutaneous nivolumab, emphasizing the importance of monitoring for immune-related adverse effects and managing them proactively to ensure ...